More News

29 Nov 2016 Idera Pharmaceuticals and Vivelix Pharmaceuticals, Ltd. Enter Into Exclusive License Agreement for the Worldwide Rights to IMO-9200
29 Nov 2016 Orchard Therapeutics Announces Strategic Alliance with Oxford BioMedica
28 Nov 2016 Boehringer Ingelheim and China Southeast University collaborate to develop new treatment approaches for hearing loss
28 Nov 2016 Chugai and Berlin-Chemie - the Menarini Group Announce Global License Agreement for an Anti-cancer Agent, PA799
23 Nov 2016 Allergan Acquires Chase Pharmaceuticals to Expand CNS R&D Pipeline and Build on Commitment to Alzheimer's Disease
22 Nov 2016 BioLineRx In-licenses Novel Anti-Inflammatory Treatment for Dry Eye Syndrome Under Strategic Collaboration with Major Global Pharmaceutical Company
22 Nov 2016 Triphase Accelerator Announces Acquisition of its First Compound, Marizomib, by Celgene Corporation
22 Nov 2016 Proteros signs second oncology collaboration with MSD on epigenetic target
22 Nov 2016 Ruga Corporation Announces Move to Houston with $20 Million Grant from CPRIT and Name Change to Aravive Biologics
22 Nov 2016 Chiesi Enhances Asthma Portfolio with Acquisition of Atopix Therapeutics
21 Nov 2016 Halozyme Provides Update On AbbVie Collaboration
21 Nov 2016 Novartis acquires Selexys Pharmaceuticals Corporation and SelG1 antibody for reduction of pain crises in sickle cell disease (SCD)
19 Nov 2016 Long-Term Analysis of All 695 Patients Enrolled in Novocure’s Phase 3 Pivotal Trial in Newly Diagnosed Glioblastoma Confirms Successful Interim Analysis Results and Demonstrates Superior Two- and Four-Year Survival Rates
17 Nov 2016 Bellicum Pharmaceuticals Recommended for $16.9 Million Award from the Cancer Prevention and Research Institute of Texas
16 Nov 2016 Genexine Enters into Clinical Research Collaboration with MSD
16 Nov 2016 Sorrento's TNK Therapeutics Subsidiary to Acquire Virttu Biologics
16 Nov 2016 Integrated BioTherapeutics, Inc. Announces Licensing Agreement with Emergent BioSolutions for Development of Equine Immunoglobulin Therapeutics for Filovirus Infections
16 Nov 2016 Bristol-Myers Squibb and Enterome Announce Immuno-Oncology Collaboration Focused on Microbiome-Derived Biomarkers, Drug Targets and Bioactive Molecules
15 Nov 2016 Selexis SA and OSE Immunotherapeutics Collaborate to Advance Development of Immunotherapies for Cancer and Autoimmune Diseases
15 Nov 2016 uniQure completes stratetic review to refocus its pipeline, reduce operating costs and deliver long-term shareholder value
15 Nov 2016 Neovacs acquires interferon alpha manufacturing technology from Amegabiotech
10 Nov 2016 Bristol-Myers Squibb Enters into New Collaboration with Johns Hopkins Focused on Immuno-Oncology Research
10 Nov 2016 Bristol-Myers Squibb Signs Exclusive Worldwide License Agreement with Nitto Denko for Targeted siRNA Therapy in Advanced Non-alcoholic Steatohepatitis (NASH) and Cirrhosis Due to NASH
10 Nov 2016 Cell Medica and Baylor College of Medicine Expand Partnership to Develop Allogeneic CAR-NKT Cells for Cancer Treatment
10 Nov 2016 Sosei Subsidiaries Heptares and Jitsubo to Develop Novel GPCR-Targeting Peptide Candidates for Severe Gastro-Intestinal Disorders

La Merie Biologics

FREE Weekly News Bulletin

2016 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing